MSSV yields 7692.31% · MRK yields 2.76%● Live data
📍 MSSV pulled ahead of the other in Year 1
Combined, MSSV + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MSSV + MRK for your $10,000?
Meso Numismatics, Inc. engages in the numismatic business in the United States and internationally. The company sells coins, paper currency, bullion, and medals through live auctions. It also offers banknote scanner, an application to identify key characteristics of a banknote; and sells its products through an online store, mesocoins.com. In addition, the company provides CELLGENIC FLOW EXOSOMES; CELLGENIC MSC, which excretes growth factors, cytokines, and proteins for regeneration of tissue; CELLGENIC LUMA that is derived from human umbilical cord mesenchymal stem cells, including potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins, and UV radiation reducing agents for skin revitalization; VITANOVAS that offers in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases; GCELL RESTORE, a closed-system medical device to harness the natural and restorative capabilities of adipose tissue; CELLGENIC SVF, an isolation kit system that has the ingredients and consumables for the extraction of adipose-derived stem cells from fat; CELLGENIC BONE MARROW; and CELLGENIC Platelet Rich Plasma for healing and reducing inflammation. Further, it offers training services to doctors. The company was formerly known as Pure Hospitality Solutions, Inc. and changed its name to Meso Numismatics, Inc. in September 2018. Meso Numismatics, Inc. was founded in 1999 and is based in Boca Raton, Florida.
Full MSSV Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.